Literature DB >> 2403062

Tolerance of preschoolers to two dosage strengths of vitamin A preparation.

R F Florentino1, C C Tanchoco, A C Ramos, T S Mendoza, E P Natividad, J B Tangco, A Sommer.   

Abstract

The tolerance to two alternative large-dosage strengths of vitamin A preparation was determined in a double-blind study involving 2471 children in two municipalities in the Philippines. Each child, aged 1-6 y, not suffering from active xerophthalmia or from nausea and/or vomiting, headache, diarrhea, and fever, was randomly given 1 mL of a syrupy suspension later identified to contain 0, 60, or 30 mg vitamin A. Clinical evaluation of subjects was done by physicians 24 h and 1 wk after dosing. Nausea and/or vomiting and headache were twice as common among children given 60 mg than those given 30 mg. Severe vomiting (1.2%) was confined to those given 60 mg. Almost all experienced their symptoms within 24 h after dosing; symptoms lasted for no more than 12-24 h. The incidence of diarrhea and fever for vitamin A recipients was not significantly different from that of those receiving placebo.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2403062     DOI: 10.1093/ajcn/52.4.694

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  7 in total

1.  Vitamin A programme in Assam probably caused hysteria.

Authors:  Keith P West; Alfred Sommer
Journal:  BMJ       Date:  2002-03-30

Review 2.  Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age.

Authors:  Aamer Imdad; Evan Mayo-Wilson; Maya R Haykal; Allison Regan; Jasleen Sidhu; Abigail Smith; Zulfiqar A Bhutta
Journal:  Cochrane Database Syst Rev       Date:  2022-03-16

3.  Single megadose vitamin A supplementation of Indian mothers and morbidity in breastfed young infants.

Authors:  S Basu; B Sengupta; P K Roy Paladhi
Journal:  Postgrad Med J       Date:  2003-07       Impact factor: 2.401

4.  Safety of one 52-mumol (50,000 IU) oral dose of vitamin A administered to neonates.

Authors:  T Agoestina; J H Humphrey; G A Taylor; A Usman; D Subardja; S Hidayat; M Nurachim; L Wu; D S Friedman; K P West
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

Review 5.  Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age.

Authors:  Aamer Imdad; Evan Mayo-Wilson; Kurt Herzer; Zulfiqar A Bhutta
Journal:  Cochrane Database Syst Rev       Date:  2017-03-11

Review 6.  Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis.

Authors:  Evan Mayo-Wilson; Aamer Imdad; Kurt Herzer; Mohammad Yawar Yakoob; Zulfiqar A Bhutta
Journal:  BMJ       Date:  2011-08-25

Review 7.  Impact of vitamin A supplementation on infant and childhood mortality.

Authors:  Aamer Imdad; Mohammad Yawar Yakoob; Christopher Sudfeld; Batool A Haider; Robert E Black; Zulfiqar A Bhutta
Journal:  BMC Public Health       Date:  2011-04-13       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.